BBOT
BRIDGEBIO (BBOT)
NASDAQ
$7.49-$0.38 (-4.89%)
Price as of Jun 23, 2026 4:10 PM EDT
  • $630.4M
    Market Cap
  • N/A
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
11.3M
+183,384.31%
6,182
N/A
Cost of Revenue
1.2M
N/A
N/A
N/A
Gross Profit
10.1M
+163,973.12%
6,182
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
Research and Development Expense
-121.2M
N/A
N/A
N/A
Depreciation and Amortization Expense
280,000
N/A
N/A
N/A
Total Operating Expenses
145.8M
+24,852.39%
584,389
N/A
Operating Profit
-145.8M
+24,852.39%
-584,389
N/A
Interest Income
11.3M
+34.25%
8.4M
N/A
Interest Expense
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
11.3M
+34.25%
8.4M
N/A
Total Nonoperating Income and Expense
11.8M
+43.88%
8.2M
N/A
Income before Taxes
-145.8M
+24,852.39%
-584,389
N/A
Income Taxes
0
N/A
0
N/A
Extraordinary Items
0
N/A
N/A
N/A
Net Income
-134.0M
-1,863.85%
7.6M
N/A
Net Income from Continuing Operations Applicable to Common
-134.0M
-1,863.85%
7.6M
N/A
Basic EPS and Net Income
-4.30
-697.22%
0.72
N/A
Diluted EPS and Net Income
-4.30
-697.22%
0.72
N/A
Basic Weighted Average Shares
31.1M
+47.16%
21.2M
N/A
Diluted Weighted Average Shares
31.1M
+46.66%
21.2M
N/A
Balance Sheet
Cash and Cash Equivalents
373.7M
+21,910.37%
1.7M
N/A
Short-Term Investments
51.8M
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
425.5M
+24,959.83%
1.7M
N/A
Total Current Assets
432.4M
+22,076.69%
1.9M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
956,000
N/A
N/A
N/A
Total Long-Term Assets
12.6M
-93.47%
192.4M
N/A
Total Assets
448.4M
+130.62%
194.4M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
534,000
N/A
N/A
N/A
Total Current Liabilities
35.0M
+18,587.04%
187,515
N/A
Total Long-Term Debt
N/A
N/A
300,000
N/A
Total Long-Term Liabilities
2.2M
N/A
N/A
N/A
Total Liabilities
37.3M
+553.26%
5.7M
N/A
Retained Earnings
-356.6M
+9,451.45%
-3.7M
N/A
Total Stockholders Equity
411.1M
+11,113.63%
-3.7M
N/A
Total Shares Outstanding
80.0M
+1,465.70%
5.1M
N/A
Cash Flow
Cash from Operating Activities
-113.9M
+14,811.10%
-763,820
N/A
Capital Expenditures
606,000
N/A
N/A
N/A
Cash from Investing Activities
73.3M
+139.85%
-184.0M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
383.4M
+105.62%
186.5M
N/A
Financials Ratio
Gross Margin
89.42%
N/A
N/A
N/A
Operating Margin
-1,285.54%
N/A
N/A
N/A
Return on Assets
-41.71%
N/A
N/A
N/A
Return on Equity
-65.81%
N/A
N/A
N/A
Revenue Growth
183,384.31%
N/A
N/A
N/A
Current Ratio
12.34
N/A
N/A
N/A
Cash Ratio
10.66
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow